To develop, manufacture, and deliver cited, reliable, high-value antibodies and research reagents that help scientists advance biological discovery with confidence.

Bioss Inc. is a Greater Boston-based life science company providing research antibodies and related reagents to scientists worldwide. Bioss offers a broad antibody catalog targeting more than 13,000 unique targets, with over 130,000 antibody products and variants available across multiple formats. These include fluorochrome-conjugated antibodies, recombinant antibodies, loading control antibodies, tag antibodies, and antibodies for key applications such as Western blot, IHC, IF, flow cytometry, ELISA, and IP.

Bioss supports research in cancer biology, neuroscience, immunology, cell signaling, metabolism, stem cell biology, infectious disease, and other areas of biomedical discovery. The catalog also includes over 1,000 antibodies specific to post-translational modifications such as phosphorylation, acetylation, and methylation, helping researchers study pathway activation, protein regulation, and disease mechanisms.

In addition to antibodies, Bioss offers recombinant proteins, ELISA kits, biochemical compounds, and custom antibody services. With responsive scientific support, knowledgeable order assistance, broad product coverage, and a commitment to reliable, high-value research tools, Bioss helps researchers find dependable solutions for their experiments.